Source: BioPortfolio

Thoratec: Thoratec Announces Presentations at Upcoming Investor Conferences

PLEASANTON Calif. Sept. 6 2011 PRNewswire Thoratec Corporation NASDAQ THOR a world leader in devicebased mechanical circulatory support therapies to save support and restore failing hearts said today it will be participating in three upcoming investor con...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
D. Keith Grossman's photo - President & CEO of Thoratec

President & CEO

D. Keith Grossman

CEO Approval Rating

67/100

Read more